Every year, thousands of Americans lace up for the Alzheimer’s Association Walk to End Alzheimer’s—the world’s largest fundraiser for Alzheimer’s care, support, and research. And every year, our team walks for our dear friend and former co-worker Lois, who is living with this disease. Lois’s grandson, Jared Fisch, pens an anecdotal essay on what it…
On June 7, 2021, the U.S. Food and Drug Administration (FDA) approved Aduhelm (aducanumab), a new Alzheimer’s drug for the treatment of the disease. Aduhelm was approved using the “accelerated approval pathway,” which can be used for a drug for a serious or life-threatening illness that provides a therapeutic advantage over existing treatment. According to…
I am into my third decade of being an elder care law attorney. Early on in my career, I realized the shortcomings of a traditional elder law practice focused exclusively on financial issues. Our clients and families needed a multi-disciplinary approach to aging and chronic care issues, which focused on helping families navigate the health…
